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Abstract
Background:    Leishmaniasis  is  a  major  parasitic  disease  in  the  tropical  regions.  However,
Leishmania infantum has recently emerged as a very important cause of opportunistic infections for
individuals positive for human immunodeficiency virus (HIV). However, there is a lack of in vitro
tests for assessing the effect of anti-parasitic drugs on the viability and proliferation of Leishmania
infantum. The aim of this study is to assess the efficacy of anti-parasitic drugs like allopurinol and
Chloralin  on  the  viability  and  proliferation  of  L.  infantum  promastigotes  by  utilizing  two
c o m p l e m e n t a r y  f l o w  c y t o m e t r i c  a p p r o a c h e s  a f t e r  e x p o s u r e  o f  t h e  p r o m a s t i g o t e s  t o  v a r i o u s
concentrations of the drugs.
Results:  The density of the cultures in the presence and absence of allopurinol was determined
by haemocytometer enumeration. The two flow cytometric approaches used to monitor the drug
effect  were:  (i)  a  quantitative  method  to  measure  cell  division  using  5-,6-carboxyfluorescein
diacetate succinimidyl ester (CFSE) staining and (ii) evaluation of cell viability by dual-staining with
the  membrane-permeable  nuclear  stain,  SBRY-14  and  propidium  iodide.  It  was  found  that
concentrations of allopurinol above 50 µ g/ml yielded a clear decrease in the proliferation rate of
the promastigotes. However, the viability results showed that about 46.8% of the promastigotes
incubated in the presence of 800 µ g/ml of allopurinol were still alive after 96 hours. In sharp
contrast, more than 90% of promastigotes treated with Chloralin 10 µ M (2.7 µ g/ml) were dead
a f t e r  4 8  h o u r s  o f  t r e a t m e n t .  T h e s e  f l o w  c y t o m e t r i c  f i n d i n g s  s u g g e s t  t h a t  a l l o p u r i n o l  h a s  a
leishmaniostatic effect while the dinitroaniline compound (Chloralin) has a leishmaniocidal effect
against promastigotes.
Conclusions:  The flow cytometric data on proliferation and viability were consistent with results
obtained from haemocytometer counts and allowed us to develop a model for assessing in vitro
the effects of medicaments like allopurinol and chloralin on L. infantum promastigotes on a cellular
level.
Introduction
Leishmaniasis is a major parasitic disease. The yearly
prevalence is estimated at 12 million people world wide,
and 200-350 million people in the tropical and subtropi-
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cal regions are at risk. In the Mediterranean region,
leishmaniasis caused by Leishmania infantum has
emerged as an important source of opportunistic infec-
tions for individuals infected with the human immuno-
deficiency virus (HIV) [1,2,3,4,5]. Dogs and wild canids
are significant reservoirs and are primarily responsible
for the persistence of the disease in this region [6,7]. The
seroprevalence of canine leishmaniasis in the mediterra-
nean region ranges between 10 to 37% [6,7]. Even in
non-tropical countries like the United States, the leish-
maniasis in dogs has been found, with new cases being
reported not only in the traditional endemic areas of
Oklahoma, Texas and Ohio but also in non-endemic
eastern coastal states like Maryland [8,9]. Pentavalent
antimonial agents (SbV) in the form of sodium stiboglu-
conate (Pentostam®) or N-methyl-D-glucamine antimo-
niate (Glucantime®) are still widely used as the drugs of
choice against leishmaniasis, despite all the deleterious
side effects like cardiac and renal toxicity, the difficulty
of administration and high costs. Other drugs utilized in-
clude amphotericin B, pentamidine and allopurinol.
However, these drugs do not have such a favorable ther-
apeutic index as the antimonials, and they require a
long-term therapeutic procedure that often induces toxic
side effects. Miltefosine is another potential alternative
drug whose efficacy is presently being evaluated
[10,11,12,13].
The therapeutic potential of allopurinol for the treat-
ment of canine leishmaniasis alone or in combination
with antimonials has been recently published [14,15,16].
However, despite of initial clinical successes, relapses
have been documented, and parasite clearance was not
achieved in dogs treated solely with allopurinol. There-
fore, the development of better and less toxic therapeutic
agents is urgently needed. The absence of an alternative
chemotherapeutic approach to the treatment of Leish-
mania infection requires urgent attention. The discovery
of the antiprotozoal effects of tubulin inhibitory com-
pounds like the benzimidazoles (albendazole) and the
dinitroanilines, have been examined for their leishmani-
acidal effects. Although the antiprotozoal effects of the
dinitroanilines have received some attention, a more de-
tailed examination of the range of effects of this group of
compounds has not been undertaken. Chloralin, like its
dinitroaniline parent (trifluralin), targets tubulin. Dini-
troanilines are good lead compounds for antiparasitic
drugs because they have already been shown to lack ac-
tivity against mammalian cells and are inexpensive to
produce [17,18,19,20,21,22].
Since the present sensitivity assays for antileishmanial
drugs have unsatisfactory features, the development of
sensitivity assays for in vitro screening of compounds
with potential antileishmanial effects (leishmaniocidal))
which have the characteristics of low price, allow high
throughput rates, and that yield fast, reliable and repro-
ducible results are urgently required. The currently
available assays have several shortcomings, which in-
clude the features of being extensively elaborate and very
expensive. Since promastigotes are the simplest stage
form of Leishmania to cultivate in vitro and therefore
used often in drug susceptibility assays [23,24,25,26], we
used promastigotes to determine the effect of allopurinol
and two other medicaments like chloralin and cyclohex-
imide on this parasite form. Using [3H]-thymidine incor-
poration assay, Chloralin isomer had showed high
efficacy on these promastigotes in an earlier study [18].
The traditional approaches of cell counting and meas-
urement of thymidine incorporation were utilized in the
present study, as well as two newly developed flow cyto-
metric methods for assessing cell proliferation and via-
bility. The stable intra-cytoplasmic dye, 5-,6-
carboxyfluorescein diacetate succinimidyl ester (CFSE)
was used as a quantitative method to measure cell divi-
sion. CFSE allowed the identification of cell progeny and
tracking and analysis of the division history of individual
cells that had undergone multiple rounds of division
[27]. CFSE attaches to parasite cells by forming stable
conjugates with aliphatic amines [28]. Upon subsequent
growth, fluorescence per cell is halved per division, pro-
viding an ideal tool for monitoring cell proliferation [29].
To determine the viability of promastigotes, the mem-
brane-permeable nuclear stain, SYBR-14, was used in
combination with propidium iodide (PI), a positively
charged nucleic acid dye unable to cross the intact plas-
ma membranes of living cells [29,30,31,32].
Results
Growth kinetics
The growth kinetics for a period of 7 days is showed in
Figure 1. The log phase of the untreated control promas-
tigotes lasted until day 2. Thereafter the parasites gradu-
ally entered the stationery phase. The maximum cell
concentration of 1.1 ×  108/ml was achieved after 72
hours.
Promastigotes treated with 4 and 10 µ g/ml of allopuri-
nol, respectively, had a similar 72 hours log phase but
reached a maximum cell density comparable to that of
the control promastigotes after 4 or 5 days. Allopurinol
concentrations higher than 50 µ g/ml produced a marked
decrease of the proliferation (Figure 1).
Promastigote proliferaton determined by CFSE staining
The proliferation of the promastigotes in the presence
and absence of allopurinol was determined by CFSE
staining. The results from each treatment were grouped
and the histogram overlaid in order to show the decreaseBMC Pharmacology (2001) 1:1 http://www.biomedcentral.com/1471-2210/1/1
in CFSE fluorescence intensity in subsequent days (Fig-
ure 2). Eight panels of overlaid histograms show the
CFSE fluorescence for control (panel 1) and allopurinol
treated promastigotes (panels 2-8). For each treatment,
a series of discrete peaks exhibiting progressive decrease
of CFSE fluorescence at different time intervals was an
indication for on-going cell divisions.
The fluorescence patterns observed in promastigotes
treated with 4 and 10 µ g/ml allopurinol (panels 2 and 3,
respectively) were similar to that of the control promas-
tigotes (panel 1). However, the fluorescence decrease
was clearly decelerated by allopurinol concentrations
above 50 µ g/ml (panels 4-8).
A distinct decrease in the fluorescence intensity in pro-
mastigotes treated with 400 and 800 µ g/ml allopurinol
was observed after 24 hours only, thereafter fluorescence
intensities remained almost stable (panel 7 and 8, re-
spectively), suggestive of an almost completely arrested
cell proliferation.
Cell divisions and generation times
Each daughter cell inherits approximately half of the
CFSE label, hence allowing monitoring and quantifica-
tion of cell divisions as indicated in Figure 3. The un-
treated control promastigotes proliferated at a constant
rate for the first 48 hours (generation time about 8
hours) and reached a peak cell density at 72 hours. Allop-
urinol concentrations above 10 µ g/ml caused a marked
decrease in cell division rates and subsequently in-
creased generation times (e.g. 12 to 15 hours and 20 to 30
hours in presence of 50 µ g/ml or 400 µ g/ml allopurinol,
respectively). During the 96 hours period of observation,
Figure 1
Growth  kinetics of p-229  promastigotes exposed  to different allopurinol concentrations µ g/ml). 0 (control,
closed squares), 4 (closed rhombuses), 10 (closed triangles), 50 (crosses) 100 (stars), 200 (open circles), 400 (open triangles)
and 800 µ g/ml allopurinol (open squares).BMC Pharmacology (2001) 1:1 http://www.biomedcentral.com/1471-2210/1/1
the control cells divided 7 times, whereas 6 cell divisions
were observed in promastigotes exposed to 50 µ g/ml al-
lopurinol and only 3 rounds of divisions were detected
when cells were exposed to a drug concentration of 400
µ g/ml (Figure 3).
Promastigote viability
The viability of promastigotes exposed to different con-
centrations of allopurinol was determined by SYBR-14
and PI dual staining and the results are given as two-pa-
rameter density-plots (Figure 4). Table 1 gives the pro-
portions (%) of the promastigotes stained mainly with
either PI, SYBR-14 or both (intermediate PI and SYBR-
14) after 48 and 96 hours, respectively. After 96 hours
only 46.8% of the promastigotes exposed to 800 µ g/ml
of allopurinol were still alive, whereas 97.1 % of the con-
trol promastigotes were alive. There was no significant
difference in the proportion of dead or live promastig-
otes between the control and the 4 or 10 µ g/ml allopuri-
nol treated cells. However, allopurinol concentrations
above 50 µ g/ml led to a clear increase in the proportion
of PI stained dead cells (Figure 4 and Table 1) after a 96
hours exposure to the drug. This finding was also ob-
served for the dual stained promastigotes. Consequently,
allopurinol treatment led to a clearly decreased propor-
tion of SYBR-14 stained (live) promastigotes.
After establishing this flow cytometric model for assess-
ing promastigote susceptibility to allopurinol, it was hy-
pothesized that other antileishmanial drugs could be
assessed by this approach and will yield similar results.
Thus, it was examined the effect of 10 µ M chloralin on
the viability of L. infantum promastigotes after 48 hours
of exposure. It was found that 91.85 % of the promastig-
Figure 2
Single parameter histograms of CFSE fluorescence of p-229 promastigotes exposed to 4, 10, 50, 100, 200, 400
and 800 µ g/ml allopurinol (panels 2-8, respectively; panel 1, unexposed control). X-axes, CFSE fluorescence intensi-
ties (four log scale).BMC Pharmacology (2001) 1:1 http://www.biomedcentral.com/1471-2210/1/1
otes were dead and stained with PI while only 7.36% of
the promastigotes remained alive and stained with
SYBR-14. In contrast, only 0.41% of the untreated pro-
mastigotes were dead and stained with PI while 98.61%
were alive and stained with SYBR-14. Of note, the in-
creasing of the dose to 100 µ M only yielded a similar pat-
tern but with higher promastigote mortality (91.77%)
(Table 2 and Figure 5).
Treatment of promastigotes with 100 µ g/ml of cyclohex-
amide yielded some mortality but it was not to the same
magnitude as with 10 µ M of chloralin. (Data not shown)
Discussion
The effect of allopurinol on L. infantum (p-229, MCAN/
ES/89/IPZ229/1/89, zymodeme MON1) promastigotes
was determined by cell counting and flow cytometric ap-
proaches. Allopurinol treatment of promastigotes led to
a gradual inhibition of cell proliferation with increasing
drug concentrations.
The rapid and precise determination of proliferation
rates and generation times by CSFE staining is beneficial
for the analysis of the effects of antileishmanial com-
pounds. The CFSE results on the growth kinetics were
consistent with those determined by cell counting. Until
now, uptake of [3H]-thymidine or other radiolabeled
compounds have been one of the most common methods
for determining cell division, or more specifically, deter-
mination of DNA replication. However, these approach-
es can only give an indication of the overall activity of cell
populations and does not give any information on the
Figure 3
Number  of  cell  divisions  of  CFSE  stained  p-229  promastigotes,  unexposed  control  (closed  squares),  and
exposed to 4 (closed rhombuses), 10 (closed triangles), 50 (crosses) 100 (stars), 200 (open circles), 400 (open
triangles) and 800 µ g/ml allopurinol (open squares).BMC Pharmacology (2001) 1:1 http://www.biomedcentral.com/1471-2210/1/1
Figure 4
Two-parameter density plots of PI and SYBR-14 stained p-229 promastigotes after 48 hours (left panels) and
96 hours (right panels). Untreated controls (panels 1 and 2), parasites exposed to 4 (panels 3 and 4), 50 (panels 5 and 6),
200 (panels 7 and 8) and 800 µ g/ml allopurinol (panels 9 and 10).BMC Pharmacology (2001) 1:1 http://www.biomedcentral.com/1471-2210/1/1
proliferative activity of individual cells [33,34,35]. Addi-
tionally, [3H]-thymidine is only taken up and/or incor-
porated by cells, which are replicating at the time the
culture is pulsed, which underestimates proliferation if
the majority of divisions occur at an early phase of the
culture [27]. Furthermore, an earlier study indicated that
the CFSE method was a more reliable and appropriate
method to determine promastigote proliferation, since
the [3H]-thymidine incorporation assay seemed to meas-
ure the overall [3H]-thymidine uptake by the cells rather
than the actual cell proliferation [30]. The combination
of SYBR-14 and PI has been used extensively in sperm vi-
ability studies [32]. In our study, SYBR-14 stained the
nuclei of live promastigotes brilliant green, while PI
stained the nuclei of dead promastigotes red. Flow cy-
tometry was effective in quantifying the three fluorescent
populations: PI, SYBR-14, and dual-stained promastig-
otes. Both dyes label DNA, thus avoiding the ambiguity
of stains targeting separate cellular organelles [32]. This
staining method was advantageous in being rapid (30
min), and the cells did not require extra processing prior
to the staining. This study demonstrates that SYBR-14,
when used in combination with PI, was effective for si-
multaneously visualizing both the living and dead popu-
lations of Leishmania promastigotes before and after
treatment with allopurinol or other drugs.
The distinct increase of dead (PI-stained) and dying (PI-
and SYBR-14-stained) promastigotes after exposure to
allopurinol concentrations higher than 50 µ g/ml gener-
ally indicated an allopurinol susceptibility of these cells.
The PI and SYBR-14 staining results were consistent
with the CFSE and the cell counting results where
marked effects of allopurinol were also observed at drug
concentrations higher than 50 µ g/ml. Furthermore, the
presence of more than 45% living promastigotes after ex-
posure to 800 µ g/ml of allopurinol for 96 hours, could
partly explain the lack of complete inhibition of [3H]-
thymidine uptake observed in an earlier study [30]. The
various analyses in our study clearly indicated that allop-
urinol had a partial and not an absolute antileishmanial
effect, even at high doses on p229 L. infantum promas-
tigotes. Clinical studies done by Cavaliero et al. [14]
showed that allopurinol treatment of L. infantum infect-
Table 1: Proportion (%) of PI, SYBR-14 and dual (PI/SYBR-14) stained p-229 promastigotes in the presence of various concentrati ons of 
allopurinol after 48 and 96 hours
Allopurinol 48 hours 96 hours
concentration
PI / PI /
PI SYBR-14 PI SYBR-14
(µ g/ml)
SYBR-14 SYBR-14
0 0.15 0.09 99.28 1.63 0.78 97.12
4 0.27 0.30 99.16 0.69 0.39 98.76
10 0.66 0.27 98.74 0.60 0.33 98.88
50 0.84 0.33 97.93 4.99 1.24 92.26
100 1.19 0.32 96.92 5.25 1.07 91.19
200 2.09 0.42 95.72 7.25 1.49 85.29
400 3.39 0.76 93.50 19.72 3.59 69.56
800 4.74 0.76 92.33 38.85 5.79 46.80
Table 2: Proportion (%) of PI, SYBR-14 and dual (PI/SYBR-14) 
stained p-229 promastigotes in the presence of various concen-







0 0.41 0.97 97.58
10 91.85 0.79 7.36
100 91.77 2.10 6.12BMC Pharmacology (2001) 1:1 http://www.biomedcentral.com/1471-2210/1/1
ed dogs led to clinical cure of the disease, but not to a
complete elimination of the parasites, and relapses of the
disease were observed in the dogs when treatment was
discontinued. Danerolle and Bourdoiseau [16] reported
that allopurinol only inhibits the growth of leishmania in
vitro and thus acts only as a leishmaniostatic rather than
a leishmanicidal drug. Although it might be tempting to
explain the clinical observations by the in vitro data ob-
served in our study, more detailed work is required to es-
tablish this assumed relationship.
In sharp contrast with the likely leishmaniostastic effect
of the allopurinol, the high efficacy of the treatment with
10 µ M-chloralin on the viability of L. infantum promas-
tigotes after 48 hours of exposure (the treatment yield
more than 90 % lethality on the promastigote) was con-
sistent with earlier results, suggesting that this com-
pound has a significant leishmanicidal effect [17,18].
The CFSE assay and the viability assay with SYBR-14 and
PI allow direct and repeated measures on the same cell
population resulting in a dynamic picture of the response
Leishmania to various concentrations of allopurinol
without killing the cells, or having to use radiolabeled
isotopes. The assessment of proliferation capacity, via-
bility and cellular changes by flow cytometry proved to
be a promising way of evaluating the susceptibility of
Leishmania promastigotes to diverse antileishmanial
compounds [30]. These assays are relatively new tools in
parasitology and pharmacology and have proved to be
interesting methods of evaluating susceptibility or resist-
ance of live Leishmania parasites to allopurinol or any
other antileishmanial compounds on a cellular level.
Figure 5
Two-parameter density plots of PI and SYBR-14 stained p-229 promastigotes after 48 hours. Untreated controls
(panel A), parasites exposed to 10 (panel B) and 100 µ M Chloralin (panel C).BMC Pharmacology (2001) 1:1 http://www.biomedcentral.com/1471-2210/1/1
Material and Methods
Parasites and drug
Promastigote forms of L. infantum (p-229, MCAN/ES/
89/IPZ229/1/89, zymodeme MON 1) were maintained
at 27° C in 25 cm2 tissue culture flasks (T25 - Corning) in
5 ml of a liquid medium (pH 7.4) supplemented with 10%
heat inactivated calf serum [31,36]. Allopurinol and cy-
cloheximeide (Sigma) was added from a 10 mg/ml stock
solution dissolved in 0.1 N NaOH and distilled water re-
spectively. Dr. A Armson kindly provided the Chloralin
(Murdoch University, Australia), and it was dissolved in
dimethylsulphoxide (DMSO). The recipe for preparation
of the liquid medium is listed in the protocols described
by Nunez et al [31].
Growth kinetics
1 ×  106/ml log phase promastigotes were inoculated into
5 ml fresh medium in T25 culture flasks in the presence
of 0, 4, 10, 50, 100, 200, 400 and 800 µ g/ml of allopuri-
nol. Assessment of growth by cell counting (Neubauer
Chamber) was determined at 24 hours intervals for 8
days. The values obtained were used to determine the
relative growth rate and the results were expressed as the
mean values of at least three experiments.
Fluorescent probes
All fluorescent stains were purchased from Molecular
Probes Europe BV (Leiden, The Netherlands). A 2.8 mg/
ml stock solution of 5-,6-carboxyfluorescein diacetate
succinimidyl ester (CFSE) was prepared in DMSO and
stored at -20° C. Propidium iodide (PI) was supplied as a
1 mg/ml solution in water. SYBR-14 was diluted in
DMSO (1 mg/ml).
CFSE as cell division marker
Promastigotes (logarithmic growth phase) were washed
(×  3) and resuspended in 2 ml PBS (6 ×  107 cells/ml) and
2.8 µ g/ml CFSE was added. Cells were incubated at 37° C
for 10 minutes during which they were carefully mixed 3
to 4 times. Several volumes of ice-cold medium supple-
mented with 10% inactivated calf serum were added, and
after centrifugation at 1200 g for 10 minutes (4° C)
stained cells were resuspended in fresh medium (density
adjusted to 5 ×  106 cells/ml) and further cultivated in 25
cm2 tissue culture flasks at 27° C in the presence of vari-
ous concentrations of allopurinol. The CFSE fluores-
cence was determined immediately after staining and
after 24, 48, 72, and 96 hours.
Staining with PI and SYBR-14
Promastigote cultures were initiated at a cell density of 5
×  106 cells/ml medium in presence of different allopuri-
nol concentrations (0 - 800 µ g/ml) or in presence of 10
µ M (2.7 µ g/ml) Chloralin. After an incubation period of
48 and 96 hours at 27° C respectively, approximately 4 ×
106 promastigotes were resuspended in 2 ml PBS, and 10
µ g/ml PI and 0.1 mg/ml of SYBR-14 were added. The
promastigotes were protected from direct light and incu-
bated at 37° C for 30 minutes before flow cytometry anal-
ysis.
Flow cytometric analysis
The green fluorescence of CFSE and SYBR-14 and the red
fluorescence of PI were excited at 488 nm (FACS Calibur,
Becton Dickinson, Heidelberg, Germany). At least ten
thousand cells were analyzed per sample and each stain-
ing experiment was repeated four times. Data analysis
was performed on fluorescence intensities that excluded
cell autofluorescence and cell debris. CELLQuest analy-
sis software was used for fluorescence determination and
data analysis while WinMDI was used to generate the 3
dimensional histogram overlays.
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